DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE-RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE IN SERBIA

被引:6
|
作者
Gajic, Ina [1 ]
Mijac, Vera [1 ]
Opavski, Natasa [1 ]
Stanojevic, Maja [1 ]
Lazarevic, Ivana [1 ]
Smitran, Aleksandra [2 ]
Hadnadev, Mirjana [3 ]
Ranin, L. [1 ]
机构
[1] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade 11000, Serbia
[2] Univ Banja Luka, Fac Med, Dept Microbiol & Immunol, Banja Luka 78000, Republic Of Srp, Bosnia & Herceg
[3] Inst Pulm Dis Vojvodina, Sremska Kamenica 21204, Serbia
关键词
Streptococcus pyogenes; Streptococcus pneumoniae; macrolide resistance; MECHANISMS; TELITHROMYCIN; SURVEILLANCE; CLINDAMYCIN; PHENOTYPES; MEF(A); SPAIN;
D O I
10.2298/ABS1401093G
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Macrolide resistance in Streptococcus pneumoniae and in group A streptococci (GAS) is a significant problem worldwide. In Serbia, data on the mechanisms of resistance and the corresponding resistance genes in streptococci are largely lacking. Therefore, we analyzed the distribution of macrolide resistance phenotypes and genotypes in 44 macrolide-resistant GAS (MRGAS) and 50 macrolide-resistant S. pneumoniae (MRSP) isolates collected in the same period. The double disk diffusion test and PCR were used to analyze resistance phenotypes and resistance genes, respectively. Among MRSP, the MLSB phenotype dominated, whereas the M phenotype was the most prevalent among MRGAS isolates. Consequently, in MRSP, the ermB gene was the most common (n=40, 80%), followed by the mefA gene (n=7,14%). In MRGAS strains, mefA dominated (n=27, 61%), followed by ermA (n=15, 33%) and ermB (n=3, 7%). In 3 MRSP isolates no resistance genes were detected, while one MRGAS strain with iMLS(B) phenotype harbored both ermA and mefA genes.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [21] Macrolide-resistant Streptococcus pyogenes in the United states, 2002-2003
    Richter, SS
    Heilmann, KP
    Beekmann, SE
    Miller, NJ
    Miller, AL
    Rice, CL
    Doern, CD
    Reid, SD
    Doern, GV
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (05) : 599 - 608
  • [22] Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A)
    Malhotra-Kumar, Surbhi
    Mazzariol, Annarita
    Van Heirstraeten, Liesbet
    Lammens, Christine
    de Rijk, Peter
    Cornaglia, Giuseppe
    Goossens, Herman
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 42 - 46
  • [23] Phenotypes and genotypes of macrolide-resistant Streptococcus pyogenes isolated in Seoul, Korea
    Bae, Sook Young
    Kim, Jang Su
    Kwon, Jung-Ah
    Yoon, Soo-Young
    Lim, Chae Seung
    Lee, Kap No
    Cho, Yunjung
    Kim, Young Kee
    Lee, Chang Kyu
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (02) : 229 - 235
  • [24] Macrolide-resistant Streptococcus pyogenes in Norway:: Population structure and resistance determinants
    Littauer, P
    Caugant, DA
    Sangvlk, M
    Hoiby, EA
    Sundsfjord, A
    Simonsen, GS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1896 - 1899
  • [25] The clinical significance of macrolide-resistant Streptococcus pneumoniae:: It's all relative
    Nuermberger, E
    Bishai, WR
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) : 99 - 103
  • [26] Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification
    Malli, Ergina
    Tatsidou, Evi
    Damani, Anthi
    Pantelidi, Kleoniki
    Petinaki, Efthimia
    Skoulakis, Charalambos
    Drougka, Eleanna
    Spiliopoulou, Iris
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (06) : 614 - 615
  • [27] Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan
    Tanaka, Yuhei
    Gotoh, Kenji
    Teramachi, Mariko
    Ishimoto, Kazuhisa
    Tsumura, Naoki
    Shindou, Shizuo
    Yamashita, Yushiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (11) : 727 - 732
  • [28] Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-Phenotype) Streptococcus pneumoniae, viridans group Streptococci, and Streptococcus pyogenes
    Ardanuy, C
    Tubau, F
    Liñares, J
    Domínguez, MA
    Pallarés, R
    Martín, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 827 - 829
  • [29] Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics
    Nishijima, T
    Saito, Y
    Aoki, A
    Toriya, M
    Toyonaga, Y
    Fujii, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) : 637 - 643
  • [30] Emergence of a novel macrolide-resistant Streptococcus pyogenes emm53 strain
    Strakova, L.
    Motlova, J.
    Jakubu, V.
    Urbaskova, P.
    Kriz, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (04) : 443 - 445